OpenURL Connection Search

Select item for more details and to access through your institution.

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
Published in:
Breast Cancer Research & Treatment, 2008, v. 112, n. 3, p. 419, doi. 10.1007/s10549-007-9879-y
By:
- Ihnen, M.;
- Müller, V.;
- Wirtz, R.;
- Schröder, C.;
- Krenkel, S.;
- Witzel, I.;
- Lisboa, B.;
- Jänicke, F.;
- Milde-Langosch, K.
Publication type:
Article
Vaginal injuries after consensual sexual intercourse — a survey among office-based gynecologists in Hamburg, Germany.
Published in:
Forensic Science, Medicine & Pathology, 2022, v. 18, n. 3, p. 352, doi. 10.1007/s12024-022-00488-z
By:
- Lohner, L.;
- Nigbur, L.;
- Klasen, C.;
- Witzel, I.;
- Garland, J.;
- Ondruschka, B.;
- Anders, S.
Publication type:
Article
Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.
Published in:
Disease Markers, 2010, v. 28, n. 2, p. 71, doi. 10.1155/2010/812509
By:
- Ihnen, M.;
- Köhler, N.;
- Kersten, J.F.;
- Milde-Langosch, K.;
- Beck, K.;
- Höller, S.;
- Müller, V.;
- Witzel, I.;
- Jänicke, F.;
- Kilic, E.
Publication type:
Article
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.
Published in:
2012
By:
- Witzel I;
- Loibl S;
- von Minckwitz G;
- Eidtmann H;
- Fehm T;
- Khandan F;
- Schmatloch S;
- Hauschild M;
- Bischoff J;
- Fasching PA;
- Mau C;
- Schem C;
- Rack B;
- Meinhold-Heerlein I;
- Liedtke C;
- Karn T;
- Huober J;
- Zu Eulenburg C;
- Issa-Nummer Y;
- Untch M
Publication type:
journal article
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab - a translational project in the neoadjuvant GeparQuinto trial.
Published in:
British Journal of Cancer, 2012, v. 107, n. 6, p. 956, doi. 10.1038/bjc.2012.353
By:
- Witzel, I;
- Loibl, S;
- von Minckwitz, G;
- Eidtmann, H;
- Fehm, T;
- Khandan, F;
- Schmatloch, S;
- Hauschild, M;
- Bischoff, J;
- Fasching, P A;
- Mau, C;
- Schem, C;
- Rack, B;
- Meinhold-Heerlein, I;
- Liedtke, C;
- Karn, T;
- Huober, J;
- zu Eulenburg, C;
- Issa-Nummer, Y;
- Untch, M
Publication type:
Article
Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.
Published in:
2010
By:
- Ihnen, M.;
- Wirtz, R. M.;
- Kalogeras, K. T.;
- Milde-Langosch, K.;
- Schmidt, M.;
- Witzel, I.;
- Eleftheraki, A. G.;
- Papadimitriou, C.;
- Jänicke, F.;
- Briassoulis, E.;
- Pectasides, D.;
- Rody, A.;
- Fountzilas, G.;
- Müller, V.;
- Jänicke, F;
- Müller, V
Publication type:
journal article
Partial PTEN deletion is linked to poor prognosis in breast cancer.
Published in:
2015
By:
- Lebok, P.;
- Kopperschmidt, V.;
- Kluth, M.;
- Hube-Magg, C.;
- Özden, C.;
- B., Taskin;
- Hussein, K.;
- Mittenzwei, A.;
- Lebeau, A.;
- Witzel, I.;
- Wölber, L.;
- Mahner, S.;
- Jänicke, F.;
- Geist, S.;
- Paluchowski, P.;
- Wilke, C.;
- Heilenkötter, U.;
- Simon, Ronald;
- Sauter, Guido;
- Terracciano, L.
Publication type:
journal article

Found: 7

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.

Vaginal injuries after consensual sexual intercourse — a survey among office-based gynecologists in Hamburg, Germany.

Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab - a translational project in the neoadjuvant GeparQuinto trial.

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.

Partial PTEN deletion is linked to poor prognosis in breast cancer.